Immune Mechanisms Responsible for Vaccination against and Clearance of Mucosal and Lymphatic Norovirus Infection

被引:88
作者
Chachu, Karen A. [1 ]
LoBue, Anna D. [2 ]
Strong, David W. [1 ]
Baric, Ralph S. [2 ]
Virgin, Herbert W. [1 ,3 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA
[2] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[3] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.ppat.1000236
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Two cardinal manifestations of viral immunity are efficient clearance of acute infection and the capacity to vaccinate against secondary viral exposure. For noroviruses, the contributions of T cells to viral clearance and vaccination have not been elucidated. We report here that both CD4 and CD8 T cells are required for efficient clearance of primary murine norovirus (MNV) infection from the intestine and intestinal lymph nodes. Further, long-lasting protective immunity was generated by oral live virus vaccination. Systemic vaccination with the MNV capsid protein also effectively protected against mucosal challenge, while vaccination with the capsid protein of the distantly related human Lordsdale virus provided partial protection. Fully effective vaccination required a broad immune response including CD4 T cells, CD8 T cells, and B cells, but the importance of specific immune cell types varied between the intestine and intestinal lymph nodes. Perforin, but not interferon gamma, was required for clearance of MNV infection by adoptively transferred T lymphocytes from vaccinated hosts. These studies prove the feasibility of both mucosal and systemic vaccination against mucosal norovirus infection, demonstrate tissue specificity of norovirus immune cells, and indicate that efficient vaccination strategies should induce potent CD4 and CD8 T cell responses.
引用
收藏
页数:13
相关论文
共 65 条
[1]  
Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P842
[2]   Norwalk virus shedding after experimental human infection [J].
Atmar, Robert L. ;
Opekun, Antone R. ;
Gilger, Mark A. ;
Estes, Mary K. ;
Crawford, Sue E. ;
Neill, Frederick H. ;
Graham, David Y. .
EMERGING INFECTIOUS DISEASES, 2008, 14 (10) :1553-1557
[3]   Antibody is critical for the clearance of murine norovirus infection [J].
Chachu, Karen A. ;
Strong, David W. ;
LoBue, Anna D. ;
Wobus, Christiane E. ;
Baric, Ralph S. ;
Virgin, Herbert W. .
JOURNAL OF VIROLOGY, 2008, 82 (13) :6610-6617
[4]   Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs [J].
Cheetham, Sonia ;
Souza, Menira ;
Meulia, Tea ;
Grimes, Sheila ;
Han, Myung Guk ;
Saif, Linda J. .
JOURNAL OF VIROLOGY, 2006, 80 (21) :10372-10381
[5]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551
[6]  
COLIGAN JE, 2007, CURRENT PROTOCOLS IM
[7]   Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants [J].
Deming, Damon ;
Sheahan, Timothy ;
Heise, Mark ;
Yount, Boyd ;
Davis, Nancy ;
Sims, Amy ;
Suthar, Mehul ;
Harkema, Jack ;
Whitmore, Alan ;
Pickles, Raymond ;
West, Ande ;
Donaldson, Eric ;
Curtis, Kristopher ;
Johnston, Robert ;
Baric, Ralph .
PLOS MEDICINE, 2006, 3 (12) :2359-2375
[8]   HUMAN ENTERIC CALICIVIRIDAE - THE COMPLETE GENOME SEQUENCE AND EXPRESSION OF VIRUS-LIKE PARTICLES FROM A GENETIC GROUP-II SMALL ROUND STRUCTURED VIRUS [J].
DINGLE, KE ;
LAMBDEN, PR ;
CAUL, EO ;
CLARKE, IN .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :2349-2355
[9]  
DOLIN R, 1972, P SOC EXP BIOL MED, V140, P578, DOI 10.3181/00379727-140-36508
[10]   Noroviruses everywhere: has something changed? [J].
Estes, Mary K. ;
Prasad, B. V. Verkataram ;
Atmar, Robert L. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (05) :467-474